Answers are grounded in this paper and cite their sources.
A peptide isolated from porcine gut according to its glucagon‐like activity in liver (bioactive enteroglucagon) has been characterized immunologically, biologically and chemically: its potency relative to pancreatic glucagon in interacting with an antiglucagon antibody, hepatic glucagon‐binding sites and hepatic adenylate cyclase was ∼100%, 20% and 10%, respectively. In contrast, it is ∼20‐times more potent than glucagon in oxyntic glands, justifying the term ‘oxyntomodulin’. Chemically, it consists in the 29 amino acid‐peptide glucagon elongated at its C‐terminal end by the octapeptide Lys—Arg—Asn—Lys—Asn—Asn—Ile &—Ala; accordingly, it is called ‘glucagon‐37’
No takes yet. Share an insight, caveat, or question.
Bataille et al. (1982) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: